This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1212/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53974210
rdf:type
wikibase:Item
schema:description
1997年學術文章 სამეცნიერო სტატია 1997年學術文章 1997년 논문 מאמר מדעי مقالهٔ علمی 1997年学术文章 artikulong pang-agham наукова стаття, опублікована в лютому 1997 ১৯৯৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья գիտական հոդված artículu científicu articol științific vědecký článek 1997年學術文章 سائنسی مضمون wissenschaftlicher Artikel 1997年学术文章 1997年學術文章 artigo científico (publicado na 1997) научни чланак artículo científico publicado en 1997 vetenskaplig artikel мақолаи илмӣ επιστημονικό άρθρο vitenskapelig artikkel videnskabelig artikel (udgivet 1997) vedecký článok 1997年学术文章 artikull shkencor bilimsel makale บทความทางวิทยาศาสตร์ artykuł naukowy научна статия scienca artikolo mokslinis straipsnis 1997年の論文 article scientifique (publié 1997) 1997年學術文章 1997年學術文章 artigo científico wetenschappelijk artikel scientific article artigo científico (publicado na 1997) мақолаи илмӣ tudományos cikk vitskapeleg artikkel article científic article scientific 1997年学术文章 bài báo khoa học 1997年学术文章 1997 nî lūn-bûn مقالة علمية naučni članak teaduslik artikkel научни чланак articolo scientifico tieteellinen artikkeli
p:P577
wds:Q53974210-9E0FC894-EE5B-4AED-872E-888A66E87201
wdt:P577
1997-02-01T00:00:00Z
p:P407
wds:Q53974210-2131D083-D9E0-4CF1-8F3E-625550FB732F
wdt:P407
wd:Q1860
rdfs:label
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
skos:prefLabel
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
schema:name
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
p:P50
wds:Q53974210-CCE7DAEF-6873-4112-8928-8111DEDC8E72 wds:Q53974210-3763DEE6-4D24-45AC-8F89-1FDBC4EA9A39 wds:Q53974210-7B3D3B4F-0D80-4273-A67F-D060F315D33A wds:Q53974210-E4349228-5F52-41C8-ACBC-01A585D1E898 wds:Q53974210-F3194FBB-F70C-4227-8D51-4052DB268452 wds:Q53974210-0121BBFF-DC2D-47D2-8A0D-754926A59F8C wds:Q53974210-0E47A893-A7BF-46A9-B761-D7360F1C9F57 wds:Q53974210-87D7FCF4-49CE-46C7-9820-CC61FCAF7A15 wds:Q53974210-A62F5FDE-8A72-453E-A2B8-ECD53390C3C7 wds:Q53974210-B55E01DB-09EE-44F3-AC50-DB3ADF4410AE wds:Q53974210-BBFB151B-BEC5-4B6D-BD7E-4982BEF6E749
wdt:P50
wd:Q59546069 wd:Q67211409 wd:Q67217197 wd:Q67217206 wd:Q67217200 wd:Q67217203 wd:Q67217194 wd:Q67217204 wd:Q16990135 wd:Q18546138 wd:Q67211437
p:P1476
wds:Q53974210-87272BAA-53F6-4BA4-8667-16AC034576F1
wdt:P1476
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
p:P304
wds:Q53974210-D2407523-6340-418E-9BC5-575657F5EDB8
wdt:P304
363-368
p:P31
wds:Q53974210-0855F9A6-112D-4BBF-924D-F11C808C8C4B
wdt:P31
wd:Q13442814
p:P921
wds:Q53974210-AC432569-8B2D-4132-AEAA-71EDC998F73E wds:Q53974210-2C0773EB-7F06-4961-9C99-1C8DCD4C333B wds:Q53974210-48203707-1DAE-45DF-8838-2F34C0D8058A
wdt:P921
wd:Q300989 wd:Q1145523 wd:Q11085
p:P698
wds:Q53974210-170E4B85-681C-43A6-8462-143F4373CDF4
wdtn:P698
n12:9040722
wdt:P698
9040722
p:P1433
wds:Q53974210-841AAB83-9EDF-4A92-A337-9CA1E702ECCC
wdt:P1433
wd:Q1161692
p:P433
wds:Q53974210-E66F9E1E-F174-4B79-8916-364E985E0339
p:P478
wds:Q53974210-A08A1069-7B9C-46B4-8974-1FEDF15A3D5F
wdt:P433
2
wdt:P478
48
p:P356
wds:Q53974210-DE7B751D-0555-40DF-8339-921080F70451
wdtn:P356
n9:WNL.48.2.363
wdt:P356
10.1212/WNL.48.2.363
skos:altLabel
Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
p:P4011
wds:Q53974210-27CF330B-7894-459A-8308-9D94D5928738
wdt:P4011
9a497e14d74ec087341896fe514061193550412c